RU2017136391A - Method of treating skin diseases, burns, superficial and deep wounds - Google Patents

Method of treating skin diseases, burns, superficial and deep wounds Download PDF

Info

Publication number
RU2017136391A
RU2017136391A RU2017136391A RU2017136391A RU2017136391A RU 2017136391 A RU2017136391 A RU 2017136391A RU 2017136391 A RU2017136391 A RU 2017136391A RU 2017136391 A RU2017136391 A RU 2017136391A RU 2017136391 A RU2017136391 A RU 2017136391A
Authority
RU
Russia
Prior art keywords
superficial
burns
skin diseases
treating skin
deep wounds
Prior art date
Application number
RU2017136391A
Other languages
Russian (ru)
Other versions
RU2690945C2 (en
RU2017136391A3 (en
Inventor
Павел Владимирович Мазин
Игорь Николаевич Токарев
Альберт Садретдинович Куламетов
Original Assignee
Федеральное государственное бюджетное образовательное учреждение высшего образования "Кировский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Кировский ГМУ Минздрава России)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное образовательное учреждение высшего образования "Кировский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Кировский ГМУ Минздрава России) filed Critical Федеральное государственное бюджетное образовательное учреждение высшего образования "Кировский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Кировский ГМУ Минздрава России)
Priority to RU2017136391A priority Critical patent/RU2690945C2/en
Publication of RU2017136391A3 publication Critical patent/RU2017136391A3/ru
Publication of RU2017136391A publication Critical patent/RU2017136391A/en
Application granted granted Critical
Publication of RU2690945C2 publication Critical patent/RU2690945C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/25—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y99/00—Subject matter not provided for in other groups of this subclass

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (1)

Способ лечения кожных заболеваний, ожогов, поверхностных и глубоких ран, заключающийся в нанесении на кожу или рану в область поражения водного мицеллярного раствора наноразмерных частиц серебра с регулярностью до трех раз в сутки в течение до десяти дней, отличающийся тем, что одновременно с нанесением на кожу или рану в область поражения водного мицеллярного раствора наноразмерных частиц серебра или перорально произвоят прием таблетированных гесперидина (50-200 мг в сутки на 2 приема после еды), диосмина (450-900 мг в сутки на 2 приема после еды) и рутозида (50-200 мг в сутки на 2 приема после еды) по-одиночке или в комбинациях друг с другом.A method of treating skin diseases, burns, superficial and deep wounds, consisting in applying to the skin or a wound in the affected area an aqueous micellar solution of nano-sized silver particles with regularity up to three times a day for up to ten days, characterized in that simultaneously or a wound in the affected area of an aqueous micellar solution of nano-sized silver particles or orally ingest tablets of hesperidin (50–200 mg per day for 2 doses after meals), diosmin (450–900 mg per day for 2 doses after units s) and ruthoside (50-200 mg per day for 2 divided doses after meals) alone or in combination with each other.
RU2017136391A 2017-10-16 2017-10-16 Method for treating skin diseases, burns, superficial and deep wounds RU2690945C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2017136391A RU2690945C2 (en) 2017-10-16 2017-10-16 Method for treating skin diseases, burns, superficial and deep wounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2017136391A RU2690945C2 (en) 2017-10-16 2017-10-16 Method for treating skin diseases, burns, superficial and deep wounds

Publications (3)

Publication Number Publication Date
RU2017136391A3 RU2017136391A3 (en) 2019-04-17
RU2017136391A true RU2017136391A (en) 2019-04-17
RU2690945C2 RU2690945C2 (en) 2019-06-07

Family

ID=66168087

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017136391A RU2690945C2 (en) 2017-10-16 2017-10-16 Method for treating skin diseases, burns, superficial and deep wounds

Country Status (1)

Country Link
RU (1) RU2690945C2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1779855A1 (en) * 2005-10-28 2007-05-02 Abdula Kurkayev Nanoparticles of a heterocrystal mineral for use as a medicament and method of producing the same
RU2611364C1 (en) * 2015-12-23 2017-02-21 Андрей Владимирович Лапочкин Antiseptic preparation and method for obtaining thereof

Also Published As

Publication number Publication date
RU2690945C2 (en) 2019-06-07
RU2017136391A3 (en) 2019-04-17

Similar Documents

Publication Publication Date Title
CA3010568A1 (en) Oromucosal nanofiber carriers for therapeutic treatment
RU2018135973A (en) PHARMACEUTICAL COMBINATION CONTAINING METROFORMIN AND DYHYDROQUERCENINE, AND ITS APPLICATION FOR TREATING CANCER
BR112016000350A8 (en) methods of treating inflammatory lesions of rosacea and uses of a pharmaceutical composition
JP2013155188A5 (en)
AR086051A1 (en) METHOD TO TREAT COLORRECTAL CANCER, COMPOSITION THAT INCLUDES AFLIBERCEPT, FOLINIC ACID, 5-FLUOROURACILO (5-FU) AND IRINOTECANO (FOLFIRI), ARTICLE MANUFACTURED, KIT
MX2021002321A (en) Novel methods.
CL2013000202A1 (en) Pharmaceutical composition and combination consisting of an activated potentiated form of an antibody against bradykinin, an activated potentiated form of a histamine and an activated enhanced form of an antibody against morphine; methods to treat diseases or conditions associated with the disease or respiratory condition.
WO2015187998A3 (en) Use of inhibitor of apoptosis protein (iap) antagonists in hiv therapy
UY31305A1 (en) DERIVATIVES OF 1,2,4,5-TETRAHIDRO-3H-BENZAZEPINAS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
AR097619A1 (en) USE OF ACETIL-COA CARBOXYLASE INHIBITORS TO TREAT ACNÉ VULGARIS
CR20150379A (en) DERIVATIVES OF PIRAZOLO-PYRIMIDINE THERAPEUTICALLY ACTIVE
AR088585A1 (en) A MEDICINAL PRODUCT TO TREAT THE PREVIOUS EYE DISEASE
FI3666258T3 (en) Method of treating prader-willi syndrome
PH12019502874A1 (en) Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments
WO2014153385A3 (en) Methods of treating metabolic disorders
EP3727334C0 (en) Pharmaceutical preparation comprising a topically released active ingredient and a heat-sensitive carrier, method of obtaining same, and use of same in the treatment of skin or mucosal infections
SG11201805457RA (en) Balloon catheter and manufacturing method thereof, and treatment method
FI3248597T3 (en) Therapeutic agent for sensorineural hearing loss
WO2017121646A8 (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
BR112014031706A2 (en) oral pharmaceutical composition; oral pharmaceutical composition form; itraconazole food effect reduction method in an individual; same-individual variability reduction method of itraconazole; method of reducing variability between individuals of itraconazole; onychomycosis treatment method; method of treating a disease or condition and method of treating cancer
CL2012003209A1 (en) Synthesis method of poly (lactic-glycolic acid) nanoparticles (plga) with pentoxifylline; pharmaceutical composition comprising nanoparticles of pest with pentoxifylline; and use of the nanoparticles loaded with pentoxifylline in the treatment of relief and prevention of chronic pain.
RU2017136391A (en) Method of treating skin diseases, burns, superficial and deep wounds
RU2017136397A (en) Method of treating skin diseases, burns, superficial and deep wounds
RU2017136376A (en) Method of treating skin diseases, burns, superficial and deep wounds
TWI799923B (en) Use of thioimidazolidinone drugs in the treatment of covid-19 disease

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20201017